AIM
AMAG

Acrospire Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Acrospire Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,400
Closed -$63K – 1772
2017
Q2 		$63K Sell
3,400
-4,200
-55% -$83.2K 0.06% 638
2017
Q1 		$171K Sell
7,600
-3,600
-32% -$86.2K 0.14% 79
2016
Q4 		$390K Sell
11,200
-2,300
-17% -$68.7K 0.16% 67
2016
Q3 		$331K Buy
13,500
+3,900
+41% +$97.5K 0.22% 10
2016
Q2 		$230K Sell
9,600
-2,600
-21% -$59.6K 0.17% 32
2016
Q1 		$285K Buy
+12,200
New +$290K 0.2% 62

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acrospire Investment Management's AMAG Position: Q3 2017 in Review

Acrospire Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q3 2017, closing a stake of 3,400 shares — an estimated $63K sold.

Acrospire Investment Management first reported a position in AMAG in Q1 2016 and held it in 6 quarters. The position peaked at $390K in Q4 2016. 187 funds tracked by Wall St. Rank hold AMAG as of Q3 2017.

  • Acrospire Investment Management reported no remaining AMAG Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 3,400 AMAG Pharmaceuticals shares in Q3 2017, an estimated $63K.
  • Acrospire Investment Management first reported a position in AMAG Pharmaceuticals in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's AMAG Pharmaceuticals position peaked at $390K in Q4 2016.
  • 187 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.